Peer Review History

Original SubmissionSeptember 5, 2024
Decision Letter - Alessandro Mengarelli, Editor

PONE-D-24-38651Gender Differences in the Impact of Fatigue on Lower Limb Landing Biomechanics and Their Association with Anterior Cruciate Ligament (ACL) Injuries: A Sysstematic Review and Meta-AnalysisPLOS ONE

Dear Dr. Cheng,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 The paper has been revised by to experts in the filed, and both of them were positive about the work. However, they highlighted a number of points that should be carefully addressed, in order to improve the overall quality of the manuscript. Presentation of some aspects, and some methodological choices should also be clarified.

Please submit your revised manuscript by Feb 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Alessandro Mengarelli

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please ensure that your PRISMA flow diagram is included in your main manuscript file as Figure 1 which is now in Figure 2; please see the PLOS ONE submission guidelines for systematic reviews and meta-analyses at https://journals.plos.org/plosone/s/submission-guidelines#loc-systematic-reviews-and-meta-analyses .

3. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition ).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories .

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

4. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

6. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

7. Please upload a copy of Supporting Information Figure/Table/etc. S1 to S11 which you refer to in your text on pages 44 and 45.

8. As required by our policy on Data Availability, please ensure your manuscript or supplementary information includes the following:

A numbered table of all studies identified in the literature search, including those that were excluded from the analyses.

For every excluded study, the table should list the reason(s) for exclusion.

If any of the included studies are unpublished, include a link (URL) to the primary source or detailed information about how the content can be accessed.

A table of all data extracted from the primary research sources for the systematic review and/or meta-analysis. The table must include the following information for each study:

Name of data extractors and date of data extraction

Confirmation that the study was eligible to be included in the review.

All data extracted from each study for the reported systematic review and/or meta-analysis that would be needed to replicate your analyses.

If data or supporting information were obtained from another source (e.g. correspondence with the author of the original research article), please provide the source of data and dates on which the data/information were obtained by your research group.

If applicable for your analysis, a table showing the completed risk of bias and quality/certainty assessments for each study or outcome. Please ensure this is provided for each domain or parameter assessed. For example, if you used the Cochrane risk-of-bias tool for randomized trials, provide answers to each of the signalling questions for each study. If you used GRADE to assess certainty of evidence, provide judgements about each of the quality of evidence factor. This should be provided for each outcome.

An explanation of how missing data were handled.

This information can be included in the main text, supplementary information, or relevant data repository. Please note that providing these underlying data is a requirement for publication in this journal, and if these data are not provided your manuscript might be rejected.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for giving me the opportunity to review this valuable study. This research is a systematic review and meta-analysis focusing on lower limb biomechanics before and after fatigue tasks, and it is very well designed. The results are clear and reasonable, and I believe a minor revision is appropriate. Below are my comments:

• Line 98-99: Please describe the method used to ensure agreement among investigators (e.g., whether recommendations by grade were applied).

• Line 173: Yes/No responses for items 1-10 in Table 2 are missing.

• Line 181: Would it be more appropriate to use "peripheral" instead of "isolated"? Similarly, consider whether "central" would be better than "whole body."

• Table 3: It may improve readability if you classify the fatigue protocol as either central or peripheral before providing detailed protocol information.

• Line 213-214: This content should be in the Discussion section, not in the Results section.

• Line 319-320: The phrase "strategy to reduce ACL loading" may be better interpreted as a compensatory mechanism in response to fatigue, rather than simply reducing the load on the ACL.

• Line 330-334: If this study does not compare athletes with non-athletes, this statement is unnecessary. Furthermore, concluding that individual responses vary could undermine the overall meaning of this review, so caution is advised.

• Line 342: As mentioned earlier, this is not about reducing the risk of ACL injuries through fatigue-induced behavior, but rather a compensatory movement in response to fatigued muscles. It's also important to note that slight knee flexion does not necessarily increase the risk of ACL injury; in fact, mild flexion could relax the MCL and LCL, potentially contributing to rotational instability. Please revisit this point from the Introduction onward.

• Line 350-351: Reference 58 reflects an in vivo perspective, and while increased quadriceps contraction can increase tension on the ACL, it also suppresses rotational stress. Please take this fact into account in your discussion.

• Line 368-375: While the content is not incorrect, if this is not a review focusing on electromyography, this discussion may be unnecessary.

• Line 416: Please add a limitation regarding the variability in fatigue tasks and the lack of consistency in task movements, and include appropriate references for this point.

Reviewer #2: There are some parts which need reconsider and revision in order to strengthen the manuscript.

The main point discussion of gender effect needs to clarify and focus. Besides, subgroup analysis of one-leg or two legs landing is also interesting.

Please see the attached file

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Makoto Asaeda

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-24-38651_reviewer-compressed.pdf
Revision 1

List of Responses

Dear Editors and Reviewers: We would like to express our gratitude for the time and effort you dedicated to reviewing our manuscript entitled “Gender Differences in the Impact of Fatigue on Lower Limb Landing Biomechanics and Their Association with Anterior Cruciate Ligament (ACL) Injuries: A Systematic Review and Meta-Analysis” (PONE-D-24-38651). Your insightful comments have significantly improved the quality of our work. On behalf of my co-authors, we thank you for allowing us to revise our manuscript. These comments are all valuable and very helpful for revising and i mproving our paper, and they provide important guiding significance to our research. We have studied the comments carefully and have made corrections, which we hope meet your approval. Revised portions are marked in red in the paper. Please find below our point-by-point responses to your feedback.

Editor:

1.Response to comment:

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Response�

We have made adjustments to the manuscript in accordance with the format requirements of PLOS ONE, including file naming and formatting changes. We have referred to the format template you provided.

2.Response to comment:

Please ensure that your PRISMA flow diagram is included in your main manuscript file as Figure 1 which is now in Figure 2;

Response�

We have moved the PRISMA flowchart from the original "Figure 2" to "Figure 1" and modified it according to the guidelines from PLOS ONE. Thank you for your reminder!

3.Response to comment:

We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

Response�

In the manuscript, we expressly state that all relevant data has been included in the manuscript and its supplementary information file.

4.Response to comment:

Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

Response�

We have ensured that the online submission form and the title in the manuscript are consistent.

5.Response to comment:

Please upload a copy of Supporting Information Figure/Table/etc. S1 to S11 which you refer to in your text on pages 44 and 45.

Response�

We have uploaded all the supporting information charts and tables mentioned in the text, ensuring they are consistent with the citations, and made some minor revisions.

6.Response to comment:

Line 187: (Table3)Lower than other studies, should be sub-analysis?

Response�

Thank you for your valuable suggestion. You are absolutely right that age can affect the reliability of results in a conventional meta-analysis. However, in the context of this study, conducting a separate subgroup analysis for this particular study may lead to inaccurate results due to the limited sample size. After performing a leave-one-out sensitivity analysis, we found that the robustness and reliability of the results were not affected, indicating that the sensitivity analysis supports the current findings and discussion. Based on this, including this study contributes to increasing the overall sample size, thereby enhancing the validity and reliability of the results.

That being said, we truly appreciate your suggestion. If you believe that excluding this study would be a more appropriate approach, we would be happy to further discuss possible solutions, including subgroup analyses or other methods that could strengthen the robustness of our findings.

Reviewer #1:

Thank you for your recognition and insightful comments on our research work!We will refer to your suggestions for further revision of the paper to meet the requirements of journal publication.

1.Response to comment:

Line 98-99: Please describe the method used to ensure agreement among investigators (e.g., whether recommendations by grade were applied).

Response�

Thank you for your advice. We have added to the manuscript methods on how to ensure researcher consistency. Add as follows:

The systematic search was conducted by two independent researchers (C.L., W.Q.). Initially, articles were screened based on titles and abstracts. If the information was unclear or ambiguous, the full texts were retrieved for further assessment. Following this, the researchers compared their findings and resolved any discrepancies through consensus discussions. In cases of unresolved disagreement, a third independent reviewer (W.P.) was consulted to provide a final decision.

To ensure agreement among the investigators, a rigorous process was followed:

1.Predefined Eligibility Criteria: All researchers applied a set of clearly defined inclusion and exclusion criteria, which were established prior to the screening. These criteria covered study design, population characteristics, interventions, and outcomes.

2.Independent Screening: Each researcher independently screened the articles at both the title/abstract and full-text stages based on the predefined criteria.

3.Consensus Process: After the initial screening, any disagreements regarding study eligibility were addressed through consensus discussions. Studies that could not be agreed upon were jointly reassessed by all researchers to reach a final decision.

4.Third-party Review: When discrepancies persisted or were particularly complex, a third independent reviewer (W.P.) , with expertise in the subject area, was consulted to resolve the issue.

5.Quality Assessment Using STROBE Guidelines: The quality of the included studies was evaluated using a modified version of the STROBE guidelines, which assessed key methodological aspects such as study design, data collection, and potential biases.

2.Response to comment:

Line 173: Yes/No responses for items 1-10 in Table 2 are missing.

Response�

We have corrected the missing data in Table 2 to ensure that all yes/No questions have full answers. Add as follows:

Table 3.Quality scores of studies included in the review

Study N1 N2 N3 N4 N5 N6 N7 N8 N9 N10 Overall

Abbey C. Thomas et al.(39) Y NA Y NA Y Y NA NA Y Y 6

Anne Benjaminse et al.(40) Y NA Y Y Y Y NA NA Y Y 7

Danielle M.Brazenet al.(41) Y Y Y Y Y Y NA NA Y Y 8

DAVID R. BELL et al.(42) Y Y Y Y Y Y NA NA Y Y 8

Dominic Gehring et al.(11) Y NA Y NA Y Y NA NA Y Y 6

Evangelos Pappas et al.(43) Y NA NA NA NA Y Y NA Y Y 5

Kristı´n Briem et al.(44) Y NA Y Y NA Y NA NA Y Y 6

Lessi G .C et al.(45) Y Y NA Y Y Y NA NA Y Y 7

Marijeanne Liederbach et al(21) Y NA Y Y NA Y Y NA Y Y 7

Michael P. Smith et al.(46) Y NA Y Y Y Y NA NA Y Y 7

Ram Haddas et al. (47) Y Y NA Y Y Y Y NA Y Y 8

Scott G. M et al.(48) Y Y NA Y Y Y NA NA Y Y 7

Thomas W. Kernozek et al.(12) Y Y Y Y Y Y NA NA Y Y 8

Zhang Qiang et al.(49) Y NA NA Y NA Y NA NA Y Y 5

N=No, NA= Not Applicable, Y=Yes. The scale questions are in Table 3

3.Response to comment:

Line 181: Would it be more appropriate to use "peripheral" instead of "isolated"? Similarly, consider whether "central" would be better than "whole body."

Response�

We reviewed the articles I included and found that All fatigue induction protocols involved peripheral fatigue, so we changed it to "All fatigue induction protocols involved peripheral fatigue."

4.Response to comment:

Table 3: It may improve readability if you classify the fatigue protocol as either central or peripheral before providing detailed protocol information.

Response�

We have labeled the fatigue protocol as "peripheral" and added more detailed information to the table to improve readability.

5.Response to comment:

Line 213-214: This content should be in the Discussion section, not in the Results section.

Response�

We have moved this section from the results section to the discussion section and made the necessary changes.

6.Response to comment:

Line 319-320: The phrase "strategy to reduce ACL loading" may be better interpreted as a compensatory mechanism in response to fatigue, rather than simply reducing the load on the ACL.

Response�

We have revised this statement in response to your suggestion to emphasize compensation mechanisms after fatigue, rather than just reducing ACL load. Changed to: “For peak knee flexion angles, both genders showed an increasing trend post-fatigue, which is considered a compensatory mechanism after fatigue and also a strategy to reduce ACL loading”

7.Response to comment:

Line 330-334: If this study does not compare athletes with non-athletes, this statement is unnecessary. Furthermore, concluding that individual responses vary could undermine the overall meaning of this review, so caution is advised.

Response�

We have removed the section on how athletes compare to non-athletes.

8.Response to comment:

Line 342: As mentioned earlier, this is not about reducing the risk of ACL injuries through fatigue-induced behavior, but rather a compensatory movement in response to fatigued muscles. It's also important to note that slight knee flexion does not necessarily increase the risk of ACL injury; in fact, mild flexion could relax the MCL and LCL, potentially contributing to rotational instability. Please revisit this point from the Introduction onward.

Response�

We have reviewed and revised this section to ensure that it is in line with the current understanding, and amended it to read: “The human body's inherent ability to adapt and regulate enables it to modify lower limb kinematics, thereby reducing the risk of ACL injuries(57). This can be considered a natural protective mechanism against landing impacts. However, while knee flexion can help mitigate impact forces to some extent, improper flexion may compromise the stability of the medial collateral ligament (MCL) and lateral collateral ligament (LCL), resulting in rotational instability of the knee and an increased risk of ACL injuries(25). This observation further elucidates why ACL injuries frequently occur during the landing phase of basketball(58).”

9.Response to comment:

Line 350-351: Reference 58 reflects an in vivo perspective, and while increased quadriceps contraction can increase tension on the ACL, it also suppresses rotational stress. Please take this fact into account in your discussion.

Response�

We have taken into account the points in reference 58 in our discussion, in particular the effect of increased quadriceps contraction on ACL load, and explained its role in reducing rotational stress. “Increased quadriceps activation during landing preparation might increase ACL loading(63). However, this activation also plays a critical role in reducing rotational stress on the knee joint. In fact, the protective effect of quadriceps activation against rotational instability can, to some extent, offset its contribution to increased ACL tension.”

10.Response to comment:

Line 368-375: While the content is not incorrect, if this is not a review focusing on electromyography, this discussion may be unnecessary.

Response�

At your suggestion, we have removed the excessive discussion of EMG to ensure that the discussion focuses on the core content of this study.

11.Response to comment:

Line 416: Please add a limitation regarding the variability in fatigue tasks and the lack of consistency in task movements, and include appropriate references for this point.

Response�

We have added limitations on fatigue tasks and motion variability to the limitations section. Add as follows�

The study has several limitations that should be considered. First, although 14 studies were included, only a few reported ankle biomechanical variables, which limited the scope of the analysis. This restriction hinders the investigation of the impact of ankle biomechanics on lower limb kinematics and ACL injury risk during landing. Second, the review focused solely on lower limb biomechanical indicators, without considering the positioning and control of the trunk and the entire kinetic chain, which could significantly influence knee biomechanics(74). Neglecting potential interactions across the kinetic chain, including trunk and hip control, may lead to an incomplete understanding of knee biomechanics. This limitation may underestimate the interdependencies between body segments and their effect on ACL injury mechanisms. Third, while the study emphasized gender, it did not perform a subgroup analysis of the effects of different landing styles and fatigue protocols on lower limb biomechanics. Variations in landing styles and fatigue protocols could alter the biomechanics of lower limb joints during landing. Finally, although the 14 studies included in this review reported data on both sexes before and after fatigue, studies focusing on a single sex were excluded. This omission may affect the comprehensive understanding of gender differences. Future research should address these limitations by incorporating a broader range of biomechanical variables, conducting subgroup analyses, and including sex-specific studies to provide a more comprehensive understanding of ACL injury mechanisms and prevention strategies.

Reviewer #2:

Thank you for your recognition and insightful comments on our research work!We will refer to your suggestions for further revision of the paper to meet the requirements of journal publication.

1.Response to comment:

There are some parts which need reconsider and revision in order to strengthen the manuscript.

Response�

We have clarified the discussion of gender effects and focused more on their specific impact in research. The relevant sections have been reorganized to improve their science and clarity.

2.Response to comment:

The main point discussion of gender effect needs to clarify and focus. Besides, subgroup analysis of one-leg or two legs landing is also interesting.

Response�

This suggestion is very useful, but since the purpose of this study is to explore gender differences, I have already written this issue in the part of limitations, and I will follow your suggestions in the later research.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Alessandro Mengarelli, Editor

Gender Differences in the Impact of Fatigue on Lower Limb Landing Biomechanics and Their Association with Anterior Cruciate Ligament (ACL) Injuries: A Systematic Review and Meta-Analysis

PONE-D-24-38651R1

Dear Dr. Li,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Alessandro Mengarelli

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the appropriate corrections. I have requested minor corrections, so I will accept it. Thank you for reporting your valuable research results.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

**********

Formally Accepted
Acceptance Letter - Alessandro Mengarelli, Editor

PONE-D-24-38651R1

PLOS ONE

Dear Dr. Li,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Alessandro Mengarelli

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .